Loading…
Indo Us Biotech (INDOUS)₹66.55−1.60%Other Agricultural Products
At the end of the Jun 2026 quarter, Indo Us Biotech's shareholders were: promoters 68.26%, FIIs 0.01%, public 31.73%. Promoter holding is unchanged on the quarter. FII holding is up 0.01 percentage points from 0.00% a year earlier. 0.00% of promoter shares were pledged. It had 4,689 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 70.14% | 70.14% | 70.15% | 70.15% | 70.15% | 70.15% | 70.15% | 70.15% | 70.15% | 70.15% | 68.26% | 68.26% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% | 0.01% |
| Public | 29.86% | 29.86% | 29.85% | 29.85% | 29.85% | 29.85% | 29.85% | 29.85% | 29.85% | 29.85% | 31.56% | 31.73% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 317 | 1,226 | 1,165 | 1,132 | 970 | 2,827 | 2,779 | 3,111 | 4,129 | 4,737 | 4,530 | 4,689 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Jagdishkumar Devjibhai Ajudiya | Promoter | 48.88% | 0.00 |
| Indo Us Agriseeds Limited | Promoter | 8.81% | 0.00 |
| Ajudia Jagdish Devjibhai Huf | Promoter | 5.72% | 0.00 |
| Malti Jagdishbhai Ajudia | Promoter | 2.92% | 0.00 |
| Priyanka Jagdishbhai Ajudia | Promoter | 2.01% | 0.00 |
| Improwised Technologies Private | Public | 2.00% | 0.00 |
| Bhartiben Rajendra Gandhi | Public | 1.51% | 0.00 |
| Pratik Rajendrabhai Gandhi | Public | 1.49% | 0.00 |
| Aumit Capital Advisors Limited | Public | 1.18% | 0.00 |
| Natvarsinh T Chavda . | Public | 1.03% | 0.00 |
Promoters held 68.26% of Indo Us Biotech at the end of the Jun 2026 quarter, down 1.89 percentage points from 70.15% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.01% (down 0.17 percentage points from 0.18% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
No. The Jun 2026 filing shows no pledged promoter shares.
Indo Us Biotech had 4,689 shareholders at the end of the Jun 2026 quarter, against 3,111 a year earlier.
Improwised Technologies Private (Public) held 2.00% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.